Korean J Psychopharmacol.
2006 Jan;17(1):91-94.
Lamotrigine as an Augmentation Agent in Treatment-Resistant Bipolar Depression: A Case Report
- Affiliations
-
- 1Department of Psychiatry, College of Medicine, The Catholic University of Korea, Seoul, Korea. wmbahk@catholic.ac.kr
Abstract
- The anticonvulsant lamotrigine has been reported to be efficacious and well tolerated in treatment of bipolar patients. Moreover, there were several reports that lamotrigine was effective for patients with treatment-resistant bipolar depression. Nevertheless, there was no report regarding the efficacy of lamotrigine as an augmentation agent in treatment-resistant bipolar depression in Korea. Here we present one case of a female patient suffering from treatment-resistant bipolar depression in which lamotrigine was successfully used as an augmentation treatment.
Keyword
MeSH Terms
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- Lamotrigine and Lithium in the Treatment of Acute Bipolar Disorder
- Successful Early Lamotrigine and Aripiprazole Augmentation of Clomipramine in Severe Obsessive-compulsive Disorder
- Lamotrigine Augmentation in Patients with Treatment-Resistant Major Depressive Disorder: A Naturalistic Study
- New Treatment Option for Bipolar Depression:Focus on Novel Antiepileptic Drugs
- Three Cases of Reversible Agranulocytosis after Treatment with Lamotrigine
